COMP <GO>
VRSK vs CTSH // EV/EBITDA & P/E VALUATION
Verisk Analytics Inc. (NASDAQ) VS. Cognizant Technology Solutions Corporation (NASDAQ) • 15-METRIC TALLY: VRSK 5
— CTSH 8
▲ EV/EBITDA & P/E VALUATION LEADER: CTSH
LAST: $190.71 (+0.48%) • MKT CAP: $24.82B
valuation
16.2x
LAST: $62.52 (-5.79%) • MKT CAP: $28.16B
valuation
7.4x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (VRSK VS. CTSH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | VRSK | CTSH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 69.90% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 53.50% | 19.60% | +33.90 | VRSK | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 16.2x | 7.4x | +8.80 | CTSH | /valuation <GO> |
| Free Cash Flow Yield | 4.80% | 9.21% | -4.41 | CTSH | /fcf-yield <GO> |
| Operating Margin | 43.70% | 16.10% | +27.60 | VRSK | /operating-margins <GO> |
| Net Profit Margin | 29.60% | 10.60% | +19.00 | VRSK | /net-margins <GO> |
| Revenue Growth (YoY) | 6.60% | 7.00% | -0.40 | CTSH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.01% | 2.17% | -1.16 | CTSH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.60 | 5.80 | -0.20 | CTSH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | CTSH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.1 | 47.1 | +8.00 | VRSK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.26 | 1.16 | +0.10 | VRSK | /macro-sensitivity <GO> |
| Forward P/E Multiple | 25.4x | 11.7x | +13.70 | CTSH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $24.82B | $28.16B | -$3.34B | CTSH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | VRSK REV | CTSH REV | VRSK GROSS % | CTSH GROSS % | VRSK FCF | CTSH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.07B | $21.11B | 69.9% | — | $1.19B | $2.60B |
| FY 2024 | $2.88B | $19.74B | 68.7% | — | $920.1M | $1.83B |
| FY 2023 | $2.68B | $19.35B | — | — | $940.0M | $1.46B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
VRSK // BETA 1.26
CTSH // BETA 1.16